Japanese biotech raises $5.3M (Japan, May 2026)
Find the investors funding Health rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trials - The Economic Times
A Japanese biotech company is developing a drug aimed at regrowing teeth. This innovative approach targets dental health and aims to provide a solution for tooth loss.
Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trials The Economic Times
| Sep 21, 2026 | ARK | $8.5M | Series A | Japan |
| Sep 17, 2026 | CADDi | $128.0M | — | Japan |
| Sep 15, 2026 | A Vinyl Bar | $5.5M | Pre-seed | Japan |
| Aug 31, 2026 | Atierra | $400K | Pre-seed | Japan |
7,183 investors back startups in Japan
You just read who funded Japanese biotech. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.